nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltitrexed—Methotrexate—systemic scleroderma	0.442	1	CrCtD
Raltitrexed—FPGS—Methotrexate—systemic scleroderma	0.156	0.739	CbGbCtD
Raltitrexed—Folic Acid—Methotrexate—systemic scleroderma	0.0584	0.2	CrCrCtD
Raltitrexed—Leucovorin—Methotrexate—systemic scleroderma	0.0584	0.2	CrCrCtD
Raltitrexed—Pralatrexate—Methotrexate—systemic scleroderma	0.0584	0.2	CrCrCtD
Raltitrexed—Pemetrexed—Methotrexate—systemic scleroderma	0.0584	0.2	CrCrCtD
Raltitrexed—Tetrahydrofolic acid—Methotrexate—systemic scleroderma	0.0584	0.2	CrCrCtD
Raltitrexed—TYMS—Methotrexate—systemic scleroderma	0.055	0.261	CbGbCtD
Raltitrexed—FPGS—connective tissue—systemic scleroderma	0.0012	0.141	CbGeAlD
Raltitrexed—FPGS—skin of body—systemic scleroderma	0.00108	0.127	CbGeAlD
Raltitrexed—FPGS—digestive system—systemic scleroderma	0.000864	0.102	CbGeAlD
Raltitrexed—FPGS—tendon—systemic scleroderma	0.000823	0.097	CbGeAlD
Raltitrexed—TYMS—connective tissue—systemic scleroderma	0.000785	0.0926	CbGeAlD
Raltitrexed—FPGS—lung—systemic scleroderma	0.000722	0.0851	CbGeAlD
Raltitrexed—TYMS—smooth muscle tissue—systemic scleroderma	0.000718	0.0847	CbGeAlD
Raltitrexed—TYMS—skin of body—systemic scleroderma	0.000709	0.0836	CbGeAlD
Raltitrexed—TYMS—digestive system—systemic scleroderma	0.000567	0.0669	CbGeAlD
Raltitrexed—TYMS—tendon—systemic scleroderma	0.00054	0.0636	CbGeAlD
Raltitrexed—TYMS—lung—systemic scleroderma	0.000473	0.0559	CbGeAlD
Raltitrexed—TYMS—Clobetasol propionate—Mometasone—systemic scleroderma	0.000159	0.117	CbGdCrCtD
Raltitrexed—TYMS—Flunisolide—Mometasone—systemic scleroderma	0.000157	0.115	CbGdCrCtD
Raltitrexed—TYMS—Triamcinolone—Mometasone—systemic scleroderma	0.000155	0.114	CbGdCrCtD
Raltitrexed—TYMS—Fluticasone Propionate—Mometasone—systemic scleroderma	0.000151	0.111	CbGdCrCtD
Raltitrexed—TYMS—Diflorasone—Mometasone—systemic scleroderma	0.000143	0.105	CbGdCrCtD
Raltitrexed—Weight decreased—Mycophenolate mofetil—systemic scleroderma	0.000141	0.00306	CcSEcCtD
Raltitrexed—Thrombocytopenia—Captopril—systemic scleroderma	0.00014	0.00303	CcSEcCtD
Raltitrexed—Alopecia—Mycophenolic acid—systemic scleroderma	0.000139	0.00303	CcSEcCtD
Raltitrexed—Pain—Mometasone—systemic scleroderma	0.000139	0.00302	CcSEcCtD
Raltitrexed—Malaise—Azathioprine—systemic scleroderma	0.000138	0.00299	CcSEcCtD
Raltitrexed—Leukopenia—Azathioprine—systemic scleroderma	0.000136	0.00297	CcSEcCtD
Raltitrexed—Renal failure—Mycophenolate mofetil—systemic scleroderma	0.000136	0.00296	CcSEcCtD
Raltitrexed—Anorexia—Captopril—systemic scleroderma	0.000136	0.00295	CcSEcCtD
Raltitrexed—Stomatitis—Mycophenolate mofetil—systemic scleroderma	0.000135	0.00294	CcSEcCtD
Raltitrexed—Asthenia—Pentoxifylline—systemic scleroderma	0.000135	0.00293	CcSEcCtD
Raltitrexed—Conjunctivitis—Mycophenolate mofetil—systemic scleroderma	0.000135	0.00293	CcSEcCtD
Raltitrexed—Cardiac failure congestive—Prednisone—systemic scleroderma	0.000135	0.00292	CcSEcCtD
Raltitrexed—Skin exfoliation—Methotrexate—systemic scleroderma	0.000134	0.00291	CcSEcCtD
Raltitrexed—Ill-defined disorder—Leflunomide—systemic scleroderma	0.000134	0.0029	CcSEcCtD
Raltitrexed—Pruritus—Pentoxifylline—systemic scleroderma	0.000133	0.00289	CcSEcCtD
Raltitrexed—Anaemia—Leflunomide—systemic scleroderma	0.000133	0.00289	CcSEcCtD
Raltitrexed—Sweating—Mycophenolate mofetil—systemic scleroderma	0.000133	0.00289	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000133	0.00288	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00013	0.00282	CcSEcCtD
Raltitrexed—Malaise—Leflunomide—systemic scleroderma	0.00013	0.00282	CcSEcCtD
Raltitrexed—Arthralgia—Azathioprine—systemic scleroderma	0.00013	0.00282	CcSEcCtD
Raltitrexed—Leukopenia—Leflunomide—systemic scleroderma	0.000129	0.0028	CcSEcCtD
Raltitrexed—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000129	0.0028	CcSEcCtD
Raltitrexed—Abdominal pain—Mometasone—systemic scleroderma	0.000128	0.00279	CcSEcCtD
Raltitrexed—Body temperature increased—Mometasone—systemic scleroderma	0.000128	0.00279	CcSEcCtD
Raltitrexed—Discomfort—Azathioprine—systemic scleroderma	0.000128	0.00279	CcSEcCtD
Raltitrexed—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.000127	0.00277	CcSEcCtD
Raltitrexed—Mouth ulceration—Methotrexate—systemic scleroderma	0.000127	0.00276	CcSEcCtD
Raltitrexed—Arrhythmia—Lisinopril—systemic scleroderma	0.000127	0.00276	CcSEcCtD
Raltitrexed—Anaemia—Mycophenolic acid—systemic scleroderma	0.000127	0.00276	CcSEcCtD
Raltitrexed—Cough—Leflunomide—systemic scleroderma	0.000126	0.00273	CcSEcCtD
Raltitrexed—Alopecia—Lisinopril—systemic scleroderma	0.000126	0.00273	CcSEcCtD
Raltitrexed—Dyspepsia—Captopril—systemic scleroderma	0.000126	0.00273	CcSEcCtD
Raltitrexed—TYMS—Budesonide—Mometasone—systemic scleroderma	0.000125	0.0923	CbGdCrCtD
Raltitrexed—Decreased appetite—Captopril—systemic scleroderma	0.000124	0.00269	CcSEcCtD
Raltitrexed—Malaise—Mycophenolic acid—systemic scleroderma	0.000124	0.00269	CcSEcCtD
Raltitrexed—Infection—Azathioprine—systemic scleroderma	0.000124	0.00269	CcSEcCtD
Raltitrexed—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000123	0.00267	CcSEcCtD
Raltitrexed—Arthralgia—Leflunomide—systemic scleroderma	0.000123	0.00266	CcSEcCtD
Raltitrexed—Constipation—Captopril—systemic scleroderma	0.000122	0.00265	CcSEcCtD
Raltitrexed—Sepsis—Methotrexate—systemic scleroderma	0.000122	0.00265	CcSEcCtD
Raltitrexed—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000122	0.00265	CcSEcCtD
Raltitrexed—Dysgeusia—Lisinopril—systemic scleroderma	0.000121	0.00263	CcSEcCtD
Raltitrexed—Discomfort—Leflunomide—systemic scleroderma	0.000121	0.00263	CcSEcCtD
Raltitrexed—Cough—Mycophenolic acid—systemic scleroderma	0.00012	0.0026	CcSEcCtD
Raltitrexed—Vomiting—Pentoxifylline—systemic scleroderma	0.00012	0.0026	CcSEcCtD
Raltitrexed—Rash—Pentoxifylline—systemic scleroderma	0.000119	0.00258	CcSEcCtD
Raltitrexed—Dermatitis—Pentoxifylline—systemic scleroderma	0.000119	0.00257	CcSEcCtD
Raltitrexed—Headache—Pentoxifylline—systemic scleroderma	0.000118	0.00256	CcSEcCtD
Raltitrexed—Feeling abnormal—Captopril—systemic scleroderma	0.000118	0.00255	CcSEcCtD
Raltitrexed—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000117	0.00254	CcSEcCtD
Raltitrexed—Infection—Leflunomide—systemic scleroderma	0.000117	0.00254	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Captopril—systemic scleroderma	0.000117	0.00253	CcSEcCtD
Raltitrexed—Asthenia—Mometasone—systemic scleroderma	0.000116	0.00253	CcSEcCtD
Raltitrexed—Discomfort—Mycophenolic acid—systemic scleroderma	0.000116	0.00251	CcSEcCtD
Raltitrexed—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000115	0.0025	CcSEcCtD
Raltitrexed—Pruritus—Mometasone—systemic scleroderma	0.000115	0.0025	CcSEcCtD
Raltitrexed—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000115	0.00249	CcSEcCtD
Raltitrexed—Anaemia—Lisinopril—systemic scleroderma	0.000114	0.00248	CcSEcCtD
Raltitrexed—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000114	0.00247	CcSEcCtD
Raltitrexed—Hepatic failure—Methotrexate—systemic scleroderma	0.000113	0.00247	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000113	0.00246	CcSEcCtD
Raltitrexed—Abdominal pain—Captopril—systemic scleroderma	0.000113	0.00245	CcSEcCtD
Raltitrexed—Body temperature increased—Captopril—systemic scleroderma	0.000113	0.00245	CcSEcCtD
Raltitrexed—Oedema—Mycophenolic acid—systemic scleroderma	0.000112	0.00244	CcSEcCtD
Raltitrexed—Anorexia—Leflunomide—systemic scleroderma	0.000112	0.00243	CcSEcCtD
Raltitrexed—Nausea—Pentoxifylline—systemic scleroderma	0.000112	0.00243	CcSEcCtD
Raltitrexed—Malaise—Lisinopril—systemic scleroderma	0.000112	0.00242	CcSEcCtD
Raltitrexed—Infection—Mycophenolic acid—systemic scleroderma	0.000111	0.00242	CcSEcCtD
Raltitrexed—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000111	0.00242	CcSEcCtD
Raltitrexed—Diarrhoea—Mometasone—systemic scleroderma	0.000111	0.00241	CcSEcCtD
Raltitrexed—Leukopenia—Lisinopril—systemic scleroderma	0.000111	0.00241	CcSEcCtD
Raltitrexed—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.00011	0.00239	CcSEcCtD
Raltitrexed—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00011	0.00238	CcSEcCtD
Raltitrexed—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000108	0.00235	CcSEcCtD
Raltitrexed—Cough—Lisinopril—systemic scleroderma	0.000108	0.00235	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000107	0.00233	CcSEcCtD
Raltitrexed—Anorexia—Mycophenolic acid—systemic scleroderma	0.000107	0.00232	CcSEcCtD
Raltitrexed—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000106	0.00231	CcSEcCtD
Raltitrexed—Arthralgia—Lisinopril—systemic scleroderma	0.000105	0.00229	CcSEcCtD
Raltitrexed—Discomfort—Lisinopril—systemic scleroderma	0.000104	0.00226	CcSEcCtD
Raltitrexed—Dyspepsia—Leflunomide—systemic scleroderma	0.000103	0.00225	CcSEcCtD
Raltitrexed—Vomiting—Mometasone—systemic scleroderma	0.000103	0.00224	CcSEcCtD
Raltitrexed—Feeling abnormal—Azathioprine—systemic scleroderma	0.000103	0.00223	CcSEcCtD
Raltitrexed—Rash—Mometasone—systemic scleroderma	0.000102	0.00222	CcSEcCtD
Raltitrexed—Asthenia—Captopril—systemic scleroderma	0.000102	0.00222	CcSEcCtD
Raltitrexed—Dermatitis—Mometasone—systemic scleroderma	0.000102	0.00222	CcSEcCtD
Raltitrexed—Decreased appetite—Leflunomide—systemic scleroderma	0.000102	0.00222	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000102	0.00222	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000102	0.00221	CcSEcCtD
Raltitrexed—Headache—Mometasone—systemic scleroderma	0.000102	0.00221	CcSEcCtD
Raltitrexed—Oedema—Lisinopril—systemic scleroderma	0.000101	0.00219	CcSEcCtD
Raltitrexed—Pruritus—Captopril—systemic scleroderma	0.000101	0.00219	CcSEcCtD
Raltitrexed—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000101	0.00219	CcSEcCtD
Raltitrexed—Pain—Leflunomide—systemic scleroderma	0.0001	0.00218	CcSEcCtD
Raltitrexed—Constipation—Leflunomide—systemic scleroderma	0.0001	0.00218	CcSEcCtD
Raltitrexed—Infection—Lisinopril—systemic scleroderma	0.0001	0.00218	CcSEcCtD
Raltitrexed—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.0001	0.00218	CcSEcCtD
Raltitrexed—Thrombocytopenia—Lisinopril—systemic scleroderma	9.89e-05	0.00215	CcSEcCtD
Raltitrexed—Dyspepsia—Mycophenolic acid—systemic scleroderma	9.87e-05	0.00214	CcSEcCtD
Raltitrexed—Neutropenia—Prednisone—systemic scleroderma	9.86e-05	0.00214	CcSEcCtD
Raltitrexed—Body temperature increased—Azathioprine—systemic scleroderma	9.84e-05	0.00214	CcSEcCtD
Raltitrexed—Abdominal pain—Azathioprine—systemic scleroderma	9.84e-05	0.00214	CcSEcCtD
Raltitrexed—Malaise—Mycophenolate mofetil—systemic scleroderma	9.78e-05	0.00212	CcSEcCtD
Raltitrexed—Hyperhidrosis—Lisinopril—systemic scleroderma	9.76e-05	0.00212	CcSEcCtD
Raltitrexed—Diarrhoea—Captopril—systemic scleroderma	9.76e-05	0.00212	CcSEcCtD
Raltitrexed—Decreased appetite—Mycophenolic acid—systemic scleroderma	9.75e-05	0.00212	CcSEcCtD
Raltitrexed—Leukopenia—Mycophenolate mofetil—systemic scleroderma	9.7e-05	0.00211	CcSEcCtD
Raltitrexed—Feeling abnormal—Leflunomide—systemic scleroderma	9.68e-05	0.0021	CcSEcCtD
Raltitrexed—Nausea—Mometasone—systemic scleroderma	9.64e-05	0.0021	CcSEcCtD
Raltitrexed—Anorexia—Lisinopril—systemic scleroderma	9.63e-05	0.00209	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Leflunomide—systemic scleroderma	9.61e-05	0.00209	CcSEcCtD
Raltitrexed—Constipation—Mycophenolic acid—systemic scleroderma	9.59e-05	0.00208	CcSEcCtD
Raltitrexed—Pain—Mycophenolic acid—systemic scleroderma	9.59e-05	0.00208	CcSEcCtD
Raltitrexed—Weight decreased—Prednisone—systemic scleroderma	9.54e-05	0.00207	CcSEcCtD
Raltitrexed—Cough—Mycophenolate mofetil—systemic scleroderma	9.46e-05	0.00206	CcSEcCtD
Raltitrexed—Body temperature increased—Leflunomide—systemic scleroderma	9.29e-05	0.00202	CcSEcCtD
Raltitrexed—Abdominal pain—Leflunomide—systemic scleroderma	9.29e-05	0.00202	CcSEcCtD
Raltitrexed—Feeling abnormal—Mycophenolic acid—systemic scleroderma	9.24e-05	0.00201	CcSEcCtD
Raltitrexed—Arthralgia—Mycophenolate mofetil—systemic scleroderma	9.23e-05	0.00201	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	9.2e-05	0.002	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	9.17e-05	0.00199	CcSEcCtD
Raltitrexed—Discomfort—Mycophenolate mofetil—systemic scleroderma	9.12e-05	0.00198	CcSEcCtD
Raltitrexed—Vomiting—Captopril—systemic scleroderma	9.07e-05	0.00197	CcSEcCtD
Raltitrexed—Rash—Captopril—systemic scleroderma	8.99e-05	0.00195	CcSEcCtD
Raltitrexed—Dermatitis—Captopril—systemic scleroderma	8.98e-05	0.00195	CcSEcCtD
Raltitrexed—Headache—Captopril—systemic scleroderma	8.93e-05	0.00194	CcSEcCtD
Raltitrexed—Dyspepsia—Lisinopril—systemic scleroderma	8.89e-05	0.00193	CcSEcCtD
Raltitrexed—Body temperature increased—Mycophenolic acid—systemic scleroderma	8.86e-05	0.00193	CcSEcCtD
Raltitrexed—Abdominal pain—Mycophenolic acid—systemic scleroderma	8.86e-05	0.00193	CcSEcCtD
Raltitrexed—Oedema—Mycophenolate mofetil—systemic scleroderma	8.85e-05	0.00192	CcSEcCtD
Raltitrexed—Infection—Mycophenolate mofetil—systemic scleroderma	8.79e-05	0.00191	CcSEcCtD
Raltitrexed—Decreased appetite—Lisinopril—systemic scleroderma	8.78e-05	0.00191	CcSEcCtD
Raltitrexed—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	8.66e-05	0.00188	CcSEcCtD
Raltitrexed—TYMS—Clobetasol propionate—Prednisone—systemic scleroderma	8.66e-05	0.0637	CbGdCrCtD
Raltitrexed—Pain—Lisinopril—systemic scleroderma	8.64e-05	0.00188	CcSEcCtD
Raltitrexed—Constipation—Lisinopril—systemic scleroderma	8.64e-05	0.00188	CcSEcCtD
Raltitrexed—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	8.55e-05	0.00186	CcSEcCtD
Raltitrexed—TYMS—Flunisolide—Prednisone—systemic scleroderma	8.55e-05	0.0629	CbGdCrCtD
Raltitrexed—Diarrhoea—Azathioprine—systemic scleroderma	8.51e-05	0.00185	CcSEcCtD
Raltitrexed—Nausea—Captopril—systemic scleroderma	8.47e-05	0.00184	CcSEcCtD
Raltitrexed—TYMS—Triamcinolone—Prednisone—systemic scleroderma	8.46e-05	0.0622	CbGdCrCtD
Raltitrexed—Anorexia—Mycophenolate mofetil—systemic scleroderma	8.43e-05	0.00183	CcSEcCtD
Raltitrexed—Asthenia—Leflunomide—systemic scleroderma	8.43e-05	0.00183	CcSEcCtD
Raltitrexed—Feeling abnormal—Lisinopril—systemic scleroderma	8.32e-05	0.00181	CcSEcCtD
Raltitrexed—Pruritus—Leflunomide—systemic scleroderma	8.31e-05	0.00181	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Lisinopril—systemic scleroderma	8.26e-05	0.00179	CcSEcCtD
Raltitrexed—Neutropenia—Methotrexate—systemic scleroderma	8.24e-05	0.00179	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	8.06e-05	0.00175	CcSEcCtD
Raltitrexed—Asthenia—Mycophenolic acid—systemic scleroderma	8.04e-05	0.00175	CcSEcCtD
Raltitrexed—Diarrhoea—Leflunomide—systemic scleroderma	8.04e-05	0.00175	CcSEcCtD
Raltitrexed—Abdominal pain—Lisinopril—systemic scleroderma	7.98e-05	0.00173	CcSEcCtD
Raltitrexed—Body temperature increased—Lisinopril—systemic scleroderma	7.98e-05	0.00173	CcSEcCtD
Raltitrexed—Pruritus—Mycophenolic acid—systemic scleroderma	7.93e-05	0.00172	CcSEcCtD
Raltitrexed—Vomiting—Azathioprine—systemic scleroderma	7.91e-05	0.00172	CcSEcCtD
Raltitrexed—Rash—Azathioprine—systemic scleroderma	7.85e-05	0.0017	CcSEcCtD
Raltitrexed—Dermatitis—Azathioprine—systemic scleroderma	7.84e-05	0.0017	CcSEcCtD
Raltitrexed—TYMS—Diflorasone—Prednisone—systemic scleroderma	7.8e-05	0.0574	CbGdCrCtD
Raltitrexed—Headache—Azathioprine—systemic scleroderma	7.8e-05	0.00169	CcSEcCtD
Raltitrexed—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	7.79e-05	0.00169	CcSEcCtD
Raltitrexed—Renal failure—Methotrexate—systemic scleroderma	7.73e-05	0.00168	CcSEcCtD
Raltitrexed—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	7.69e-05	0.00167	CcSEcCtD
Raltitrexed—Diarrhoea—Mycophenolic acid—systemic scleroderma	7.67e-05	0.00167	CcSEcCtD
Raltitrexed—Stomatitis—Methotrexate—systemic scleroderma	7.66e-05	0.00166	CcSEcCtD
Raltitrexed—Conjunctivitis—Methotrexate—systemic scleroderma	7.64e-05	0.00166	CcSEcCtD
Raltitrexed—Constipation—Mycophenolate mofetil—systemic scleroderma	7.57e-05	0.00164	CcSEcCtD
Raltitrexed—Pain—Mycophenolate mofetil—systemic scleroderma	7.57e-05	0.00164	CcSEcCtD
Raltitrexed—Arrhythmia—Prednisone—systemic scleroderma	7.54e-05	0.00164	CcSEcCtD
Raltitrexed—Sweating—Methotrexate—systemic scleroderma	7.53e-05	0.00164	CcSEcCtD
Raltitrexed—Vomiting—Leflunomide—systemic scleroderma	7.47e-05	0.00162	CcSEcCtD
Raltitrexed—Alopecia—Prednisone—systemic scleroderma	7.46e-05	0.00162	CcSEcCtD
Raltitrexed—Rash—Leflunomide—systemic scleroderma	7.41e-05	0.00161	CcSEcCtD
Raltitrexed—Dermatitis—Leflunomide—systemic scleroderma	7.4e-05	0.00161	CcSEcCtD
Raltitrexed—Nausea—Azathioprine—systemic scleroderma	7.39e-05	0.00161	CcSEcCtD
Raltitrexed—Headache—Leflunomide—systemic scleroderma	7.36e-05	0.0016	CcSEcCtD
Raltitrexed—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	7.29e-05	0.00158	CcSEcCtD
Raltitrexed—Asthenia—Lisinopril—systemic scleroderma	7.25e-05	0.00157	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	7.23e-05	0.00157	CcSEcCtD
Raltitrexed—Pruritus—Lisinopril—systemic scleroderma	7.14e-05	0.00155	CcSEcCtD
Raltitrexed—Vomiting—Mycophenolic acid—systemic scleroderma	7.13e-05	0.00155	CcSEcCtD
Raltitrexed—Rash—Mycophenolic acid—systemic scleroderma	7.07e-05	0.00154	CcSEcCtD
Raltitrexed—Dermatitis—Mycophenolic acid—systemic scleroderma	7.06e-05	0.00153	CcSEcCtD
Raltitrexed—Headache—Mycophenolic acid—systemic scleroderma	7.02e-05	0.00153	CcSEcCtD
Raltitrexed—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	6.99e-05	0.00152	CcSEcCtD
Raltitrexed—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	6.99e-05	0.00152	CcSEcCtD
Raltitrexed—Nausea—Leflunomide—systemic scleroderma	6.98e-05	0.00152	CcSEcCtD
Raltitrexed—Diarrhoea—Lisinopril—systemic scleroderma	6.91e-05	0.0015	CcSEcCtD
Raltitrexed—TYMS—Budesonide—Prednisone—systemic scleroderma	6.83e-05	0.0503	CbGdCrCtD
Raltitrexed—Ill-defined disorder—Prednisone—systemic scleroderma	6.82e-05	0.00148	CcSEcCtD
Raltitrexed—Anaemia—Prednisone—systemic scleroderma	6.79e-05	0.00148	CcSEcCtD
Raltitrexed—Nausea—Mycophenolic acid—systemic scleroderma	6.66e-05	0.00145	CcSEcCtD
Raltitrexed—Malaise—Prednisone—systemic scleroderma	6.63e-05	0.00144	CcSEcCtD
Raltitrexed—TYMS—Danazol—Prednisone—systemic scleroderma	6.55e-05	0.0482	CbGdCrCtD
Raltitrexed—Vomiting—Lisinopril—systemic scleroderma	6.42e-05	0.00139	CcSEcCtD
Raltitrexed—Rash—Lisinopril—systemic scleroderma	6.37e-05	0.00138	CcSEcCtD
Raltitrexed—Dermatitis—Lisinopril—systemic scleroderma	6.36e-05	0.00138	CcSEcCtD
Raltitrexed—Asthenia—Mycophenolate mofetil—systemic scleroderma	6.35e-05	0.00138	CcSEcCtD
Raltitrexed—Headache—Lisinopril—systemic scleroderma	6.33e-05	0.00137	CcSEcCtD
Raltitrexed—Pruritus—Mycophenolate mofetil—systemic scleroderma	6.26e-05	0.00136	CcSEcCtD
Raltitrexed—Arthralgia—Prednisone—systemic scleroderma	6.26e-05	0.00136	CcSEcCtD
Raltitrexed—Alopecia—Methotrexate—systemic scleroderma	6.23e-05	0.00135	CcSEcCtD
Raltitrexed—Discomfort—Prednisone—systemic scleroderma	6.18e-05	0.00134	CcSEcCtD
Raltitrexed—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	6.05e-05	0.00132	CcSEcCtD
Raltitrexed—Dysgeusia—Methotrexate—systemic scleroderma	6.01e-05	0.00131	CcSEcCtD
Raltitrexed—Nausea—Lisinopril—systemic scleroderma	6e-05	0.0013	CcSEcCtD
Raltitrexed—Oedema—Prednisone—systemic scleroderma	6e-05	0.0013	CcSEcCtD
Raltitrexed—Infection—Prednisone—systemic scleroderma	5.96e-05	0.00129	CcSEcCtD
Raltitrexed—Hyperhidrosis—Prednisone—systemic scleroderma	5.8e-05	0.00126	CcSEcCtD
Raltitrexed—Anorexia—Prednisone—systemic scleroderma	5.72e-05	0.00124	CcSEcCtD
Raltitrexed—Ill-defined disorder—Methotrexate—systemic scleroderma	5.7e-05	0.00124	CcSEcCtD
Raltitrexed—Anaemia—Methotrexate—systemic scleroderma	5.68e-05	0.00123	CcSEcCtD
Raltitrexed—Vomiting—Mycophenolate mofetil—systemic scleroderma	5.63e-05	0.00122	CcSEcCtD
Raltitrexed—Rash—Mycophenolate mofetil—systemic scleroderma	5.58e-05	0.00121	CcSEcCtD
Raltitrexed—Dermatitis—Mycophenolate mofetil—systemic scleroderma	5.57e-05	0.00121	CcSEcCtD
Raltitrexed—Headache—Mycophenolate mofetil—systemic scleroderma	5.54e-05	0.0012	CcSEcCtD
Raltitrexed—Malaise—Methotrexate—systemic scleroderma	5.54e-05	0.0012	CcSEcCtD
Raltitrexed—Leukopenia—Methotrexate—systemic scleroderma	5.5e-05	0.00119	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Prednisone—systemic scleroderma	5.46e-05	0.00119	CcSEcCtD
Raltitrexed—Cough—Methotrexate—systemic scleroderma	5.36e-05	0.00116	CcSEcCtD
Raltitrexed—Dyspepsia—Prednisone—systemic scleroderma	5.28e-05	0.00115	CcSEcCtD
Raltitrexed—Nausea—Mycophenolate mofetil—systemic scleroderma	5.26e-05	0.00114	CcSEcCtD
Raltitrexed—Arthralgia—Methotrexate—systemic scleroderma	5.23e-05	0.00114	CcSEcCtD
Raltitrexed—Decreased appetite—Prednisone—systemic scleroderma	5.21e-05	0.00113	CcSEcCtD
Raltitrexed—Discomfort—Methotrexate—systemic scleroderma	5.17e-05	0.00112	CcSEcCtD
Raltitrexed—Constipation—Prednisone—systemic scleroderma	5.13e-05	0.00111	CcSEcCtD
Raltitrexed—Infection—Methotrexate—systemic scleroderma	4.98e-05	0.00108	CcSEcCtD
Raltitrexed—Feeling abnormal—Prednisone—systemic scleroderma	4.94e-05	0.00107	CcSEcCtD
Raltitrexed—Thrombocytopenia—Methotrexate—systemic scleroderma	4.91e-05	0.00107	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Prednisone—systemic scleroderma	4.9e-05	0.00107	CcSEcCtD
Raltitrexed—Hyperhidrosis—Methotrexate—systemic scleroderma	4.85e-05	0.00105	CcSEcCtD
Raltitrexed—Anorexia—Methotrexate—systemic scleroderma	4.78e-05	0.00104	CcSEcCtD
Raltitrexed—Abdominal pain—Prednisone—systemic scleroderma	4.74e-05	0.00103	CcSEcCtD
Raltitrexed—Body temperature increased—Prednisone—systemic scleroderma	4.74e-05	0.00103	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	4.57e-05	0.000992	CcSEcCtD
Raltitrexed—Dyspepsia—Methotrexate—systemic scleroderma	4.41e-05	0.000959	CcSEcCtD
Raltitrexed—Decreased appetite—Methotrexate—systemic scleroderma	4.36e-05	0.000947	CcSEcCtD
Raltitrexed—Asthenia—Prednisone—systemic scleroderma	4.3e-05	0.000935	CcSEcCtD
Raltitrexed—Pain—Methotrexate—systemic scleroderma	4.29e-05	0.000931	CcSEcCtD
Raltitrexed—Pruritus—Prednisone—systemic scleroderma	4.24e-05	0.000922	CcSEcCtD
Raltitrexed—Feeling abnormal—Methotrexate—systemic scleroderma	4.13e-05	0.000897	CcSEcCtD
Raltitrexed—Diarrhoea—Prednisone—systemic scleroderma	4.1e-05	0.000892	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Methotrexate—systemic scleroderma	4.1e-05	0.00089	CcSEcCtD
Raltitrexed—Abdominal pain—Methotrexate—systemic scleroderma	3.96e-05	0.000861	CcSEcCtD
Raltitrexed—Body temperature increased—Methotrexate—systemic scleroderma	3.96e-05	0.000861	CcSEcCtD
Raltitrexed—Vomiting—Prednisone—systemic scleroderma	3.81e-05	0.000828	CcSEcCtD
Raltitrexed—Rash—Prednisone—systemic scleroderma	3.78e-05	0.000822	CcSEcCtD
Raltitrexed—Dermatitis—Prednisone—systemic scleroderma	3.78e-05	0.000821	CcSEcCtD
Raltitrexed—Headache—Prednisone—systemic scleroderma	3.76e-05	0.000816	CcSEcCtD
Raltitrexed—Asthenia—Methotrexate—systemic scleroderma	3.6e-05	0.000781	CcSEcCtD
Raltitrexed—Nausea—Prednisone—systemic scleroderma	3.56e-05	0.000774	CcSEcCtD
Raltitrexed—Pruritus—Methotrexate—systemic scleroderma	3.55e-05	0.00077	CcSEcCtD
Raltitrexed—Diarrhoea—Methotrexate—systemic scleroderma	3.43e-05	0.000745	CcSEcCtD
Raltitrexed—Vomiting—Methotrexate—systemic scleroderma	3.19e-05	0.000692	CcSEcCtD
Raltitrexed—Rash—Methotrexate—systemic scleroderma	3.16e-05	0.000687	CcSEcCtD
Raltitrexed—Dermatitis—Methotrexate—systemic scleroderma	3.16e-05	0.000686	CcSEcCtD
Raltitrexed—Headache—Methotrexate—systemic scleroderma	3.14e-05	0.000682	CcSEcCtD
Raltitrexed—Nausea—Methotrexate—systemic scleroderma	2.98e-05	0.000647	CcSEcCtD
